【直报网5月6日讯】（新京报 李丹丹）除麻醉药品和第一类精神药品外，不再实行最高零售限价管理，药价主要由市场竞争形成。

CNDSN May 7th news (Beijing News Li Dandan) in addition to narcotic drugs and psychotropic substances, no longer apply the maximum retail price management, price is mainly formed by market competition.

6月1日起我国将取消绝大部分药品政府定价，这意味着，施行近20年的“药品政府定价制度”将正式终结。

Since June 1st, China will cancel most of the medicine of government pricing, which means, the implementation of nearly 20 years of "government drug pricing system" will officially end.

昨日，国家发改委会同国家卫生计生委、人力资源和社会保障部等部门联合发文，决定从6月1日起取消绝大部分药品政府定价，完善药品采购机制，发挥医保控费作用，药品实际交易价格主要由市场竞争形成。

Yesterday, the national development and Reform Commission and the national health and Family Planning Commission, Ministry of human resources and social security and other departments jointly issued a document, the decision from June 1st to cancel most of government pricing of drugs, improve the drug procurement mechanism, play a role in drug control health care costs, the actual transaction price is mainly formed by market competition.

麻醉药品仍由政府定价

Narcotic drugs still government pricing

根据《关于印发推进药品价格改革意见的通知》（以下简称《通知》），除麻醉药品和第一类精神药品仍暂时由国家发展改革委实行最高出厂价格和最高零售价格管理外，对其他药品政府定价均予以取消，不再实行最高零售限价管理。

According to "promote the reform of drug prices on the issuance of the views of the notice" (hereinafter referred to as the "notice"), in addition to narcotic drugs and psychotropic substances still temporarily by the national development and Reform Commission to implement the highest ex factory price and the retail price management, to other government pricing of drugs are to be canceled, no longer apply the maximum retail price management.

《通知》强调，建立科学合理的药品价格形成机制，要充分发挥市场配置资源的决定性作用，同时要更好地发挥政府作用，加强事中事后监管。取消药品政府定价后，要做好与药品采购、医保支付等改革政策的衔接，强化医药费用和价格行为监管。

"Notice" stressed, establish a scientific and reasonable drug price formation mechanism, give full play to the decisive role of the market in the allocation of resources, and to better play the role of government, strengthen supervision. Cancel the government pricing of drugs, must join the drug procurement, Medicare payment reform policies, strengthen the medical cost and price regulation.

发改委：改革时机成熟

NDRC: ripe for reform

1996年9月，国家计委颁布了《药品价格管理暂行办法》。2000年，价格主管部门对医保目录内药品和目录外特殊药品实行政府指导价(最高零售限价)管理。

In 1996 September, the State Planning Commission issued the "Interim Measures for the management of drug prices". In 2000, the competent department of price of the insurance catalogue of drugs and drug directory special implementation of government guidance management (maximum retail price).

昨日，发改委在回答改革时机选择时表示，药品价格管理面临的体制机制环境已发生深刻变化，药品市场充分竞争，公立医院销售药品价格全部通过集中招标采购确定，医保控费能力和药品价格市场监管能力也明显增强。这些变化，为取消药品最高零售限价创造了条件。从最高零售限价管理方式本身来看，也存在明显不适应形势变化的地方。因此，加快推进药品价格改革，取消药品最高零售限价管理，建立新的药品价格形成机制势在必行，时机也已经成熟。

Yesterday, the NDRC said in response to the timing of the reform, the environment mechanism faces drug price management has undergone profound changes, full competition in drug market, public hospital drug sales prices all through centralized bidding, controlling health care costs and drug prices also significantly enhance the ability of market regulation. These changes, to create the conditions for the abolition of the maximum retail price of drugs. From the highest retail price management itself, there are obviously not adapt to the changing situation of the place. Therefore, to accelerate the reform of drug prices, cancel the maximum retail price of drugs management, the establishment of new drug price formation mechanism be imperative, timing is ripe.

焦点

Focus

药品价格怎么定？

The drug price how?

医保基金支付的药品：通过制定医保支付标准探索引导药品价格合理形成的机制。

The health insurance fund of the drug: by making Medicare payment standard exploration guide reasonable price formation mechanism of drug.

专利药品、独家生产药品：通过建立公开透明、多方参与的谈判机制形成价格。

Patent medicine, drug production: exclusive negotiation mechanism through the establishment of transparent, participatory price formation.

医保目录外的血液制品、国家统一采购的预防免疫药品、国家免费艾滋病抗病毒治疗药品和避孕药具：通过招标采购或谈判形成价格。

Blood products, health insurance directory outside the national unified procurement of drugs, national immunization free antivirus treatment of AIDS drugs and contraceptives: through the formation of price bidding or negotiation.

其他原来实行市场调节价的药品：继续由生产经营者依据生产经营成本和市场供求情况，自主制定价格。

Other original market drugs: continued by production operators according to production costs and market supply and demand situation, independent pricing.

Sound

药企：高价药预计将“放低身段”

Pharmaceutical companies: high priced drugs are expected to lower the figure ""

“低价不等于优质，优质也不等于高价。将药品价格交由市场，是对百姓负责任的做法。”昨日，华润医药商业集团董事长陈济生表示，已关注到国家发改委的药价改革新政，她认为，市场化竞争形成实际交易价格，进而实现对药品的优胜劣汰，最终会对百姓的用药安全产生积极的作用。

"Price is not equal to the quality, quality is not equal to the price. The drug price by the market, is the practice of the people responsible." Yesterday, Huarun commercial pharmaceutical group chairman Chen Jisheng said, has paid attention to the national development and Reform Commission of drug price reform new deal, she thinks, market competition and form the actual transaction price, and then achieve the drugs on the survival of the fittest, people will eventually have a positive for drug safety.

药企将更关注成本控制

Pharmaceutical companies will pay more attention to cost control

取消政府定价后，是否意味着为药企“松绑”？陈济生对此表示，原先政府实行的最高零售限价实际上意义不大。“由于审批的价格并不关注真正的制造成本，很多不属于制造成本的元素，都摊入了药品价格。”

Cancel the government pricing, whether that means for pharmaceutical companies to "relax"? Chen Jisheng said, the original government imposed a maximum retail price actually has little significance. "The approval of the price is not really concerned about the manufacturing cost, many do not belong to the manufacturing cost of the elements, are spread out in drug price."

她解释，大家对于药品价格普遍存在一种误解，觉得某个药品“成本几毛钱，卖出去就要几块”，实际上，这是将药品的制作、管理、营销成本都加进去了。政府“管”的只是最高零售价，但实际上并未去“管”最高成本。“在这种情况下，企业若将成本压低，但市场价格合理，体现的是企业的能力。”

She explained, the drug price there is a common misconception that a drug, "the cost of a few cents, sold to a few blocks", in fact, this is the drug production, management, marketing costs are added. "The government" is the maximum retail price, but did not actually go to the "tube" highest cost. "In this case, if the enterprise will cost down, but the market price is reasonable, is the embodiment of the ability of enterprises."

陈济生认为，在取消政府定价之后，作为药企将会更加关注各项成本的控制，自我约束会加强。“药品不断提升工艺，保障质量，才有能力竞争。质量高、疗效好的药物会胜出，劣质的药物会被市场淘汰。整个趋势会是良性的。”

Chen Jisheng said, after the cancellation of government pricing, as pharmaceutical companies will be more concerned about the cost control, will strengthen self-discipline. "The drugs improve technology, quality assurance, have the ability to compete. Drugs with high quality, good curative effect will win, the market will be eliminated inferior drugs. The trend can be healthy. "

医院开药价“不会上涨”

The hospital drug prices will not rise ""

在北京，医院药品早已实行政府招标采购。针对百姓关注的医院开药价格，陈济生表示“不会上涨”。她说，首先在现行药品集中招标采购的机制下，招采价格会体现“社会行情”的尺度，药品价格和质量会在商谈的过程中，达到一个平衡点，本身就不会被抬到一个虚高的价格。另外，医院是否乱开药、开昂贵的药物，也已经纳入了医保部门的控制范围之内。因此，新政对医院药品价格不会有太大影响。

In Beijing, the implementation of government procurement of drugs already in hospital. For people concerned about the hospital prescription price, "said Chen Jisheng will not rise". She said, first in the current mechanism of centralized drug bidding under, strokes prices will reflect the "social market" scale, drug price and quality in the negotiation process, achieve a balance point, itself will not be lifted to a high price. In addition, whether the hospital prescription, open expensive drugs, have also been included within the scope of control of medical insurance department. Therefore, the new deal has much impact on hospital drug prices will not.

另外，按照新政，今后由医保基金支付的药品，会由人社部门同药企“议价”。陈济生分析，由于医保部门本身有总额控制的动力，此举预计会带来一个变化，就是逐渐令一些价格水平高于同类产品的药品，比如合资药、百姓过去“望尘莫及”的高价药品“放低身段”。

In addition, according to the new deal, will be paid by the health insurance fund of the drug, will by the community sector with pharmaceutical companies "bargaining". Chen Jisheng analysis, due to the medical insurance department itself has total control power, the move is expected to bring about a change, is gradually to some price level higher than similar products such as medicine, medicine, joint venture "far behind" the people of the past "high priced drugs to lower the figure".

她分析，今后这类药品必须通过降低成本，下沉到基层医疗，才能得到医保的支持，最终才能在医疗市场占据份额。“预计今后市民的用药水平也会因此提高，可以说是益民好事。”▲

Her analysis, this kind of drug in the future must cut the cost, sink to the grassroots medical insurance, to support, and ultimately to share in the medical market. "The public is expected in the future will therefore improve the level of medication, can be said to be good yimin." 3

责任编辑：小申

Editor: small Shen